A minimal common outcome measure set for COVID-19 clinical research

JC Marshall, S Murthy, J Diaz, NK Adhikari… - The lancet infectious …, 2020 - thelancet.com
Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …

Personalised care planning for adults with chronic or long‐term health conditions

A Coulter, VA Entwistle, A Eccles… - Cochrane Database …, 2015 - cochranelibrary.com
Background Personalised care planning is a collaborative process used in chronic condition
management in which patients and clinicians identify and discuss problems caused by or …

The economic burden of adults with major depressive disorder in the United States (2010 and 2018)

PE Greenberg, AA Fournier, T Sisitsky, M Simes… - …, 2021 - Springer
Background The incremental economic burden of US adults with major depressive disorder
(MDD) was estimated at US210.5billionin2010(year2012values) …

[HTML][HTML] Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey

J Alonso, G Vilagut, P Mortier, M Ferrer, I Alayo… - Revista de psiquiatria y …, 2021 - Elsevier
Introduction Healthcare workers are vulnerable to adverse mental health impacts of the
COVID-19 pandemic. We assessed prevalence of mental disorders and associated factors …

Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized …

V Popova, EJ Daly, M Trivedi… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: About one-third of patients with depression fail to achieve remission despite
treatment with multiple antidepressants. This study compared the efficacy and safety of …

Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double …

M Fedgchin, M Trivedi, EJ Daly… - International Journal …, 2019 - academic.oup.com
Background About one-third of patients with depression fail to achieve remission despite
treatment with multiple antidepressants and are considered to have treatment-resistant …

Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health …

S Evans-Lacko, S Aguilar-Gaxiola… - Psychological …, 2018 - cambridge.org
BackgroundThe treatment gap between the number of people with mental disorders and the
number treated represents a major public health challenge. We examine this gap by socio …

Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe

AM Ruscio, LS Hallion, CCW Lim… - JAMA …, 2017 - jamanetwork.com
Importance Generalized anxiety disorder (GAD) is poorly understood compared with other
anxiety disorders, and debates persist about the seriousness of this disorder. Few data exist …

[HTML][HTML] Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression—TRANSFORM-3

R Ochs-Ross, EJ Daly, Y Zhang, R Lane, P Lim… - The American Journal of …, 2020 - Elsevier
Background Elderly patients with major depression have a poorer prognosis, are less
responsive to treatment, and show greater functional decline compared with younger …

Barriers to mental health treatment: results from the WHO World Mental Health surveys

LH Andrade, J Alonso, Z Mneimneh, JE Wells… - Psychological …, 2014 - cambridge.org
BackgroundTo examine barriers to initiation and continuation of mental health treatment
among individuals with common mental disorders. MethodData were from the World Health …